5-methylcytosine has been researched along with Intestinal Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barazeghi, E; Hellman, P; Norlén, O; Prabhawa, S; Stålberg, P; Westin, G | 1 |
Bird, A; Bishop, SM; Clarke, AR; Guy, J; Hendrich, B; Keightley, PD; MacDougall, E; Millar, CB; Sansom, OJ; Selfridge, J | 1 |
2 other study(ies) available for 5-methylcytosine and Intestinal Neoplasms
Article | Year |
---|---|
Decrease of 5-hydroxymethylcytosine and TET1 with nuclear exclusion of TET2 in small intestinal neuroendocrine tumors.
Topics: 5-Methylcytosine; Adult; Aged; Cell Nucleus; Dioxygenases; DNA-Binding Proteins; Humans; Intestinal Neoplasms; Intestine, Small; Middle Aged; Mixed Function Oxygenases; Neuroendocrine Tumors; Proto-Oncogene Proteins | 2018 |
Enhanced CpG mutability and tumorigenesis in MBD4-deficient mice.
Topics: 5-Methylcytosine; Alleles; Amino Acid Sequence; Animals; Base Pair Mismatch; Cytosine; Deamination; Dinucleoside Phosphates; DNA Methylation; DNA Repair; Endodeoxyribonucleases; Female; Gene Targeting; Genes, APC; Genetic Predisposition to Disease; Intestinal Neoplasms; Intestine, Large; Loss of Heterozygosity; Male; Mice; Mice, Inbred C57BL; Molecular Sequence Data; Point Mutation; Suppression, Genetic | 2002 |